Perspectives on Health Care
997 total results. Page 24 of 40.
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, David S. Greenberg, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
The end of 2018 saw good news for hospitals affected by the lowered Medicare Part B reimbursement rates for certain outpatient drugs that went into effect January 1, 2018.
D. Jacques Smith, Stephanie Trunk, Randall A. Brater, David S. Greenberg, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
In Los Angeles alone, the LA City Attorney's Office has in recent years initiated numerous lawsuits against hospitals and nursing facilities for homeless patient “dumping” – a practice generally described as discharging homeless persons without regard to their safety or ability to find shelter.
Lowell C. Brown, Debra Albin-Riley, Douglas A. Grimm, Thomas E. Jeffry, Jr., D. Jacques Smith, Sarah G. Benator
We are very pleased to announce that our Health Care attorneys will be hosting two Medical Staff Leaders and the Law Conferences in 2019.
Headlines that Matter for Companies and Executives in Regulated Industries
We are pleased to announce that Arent Fox professionals will be presenting during the 2019 Chief of Staff Boot Camp hosted by The Institute for Medical Leadership.
The Office of Inspector General for the Department of Health and Human Services recently published its Semiannual Report to Congress, for the period April 1 to September 30, 2018.
Arent Fox FDA Associate Emily Leongini will present at CBI’s Bio/Pharma Compliance Congress on Non-promotional Activities.
On November 30, HRSA announced that it is “notifying all stakeholders that the secure pricing component of the 340B Office of Pharmacy Affairs Information System (340B OPAIS) will be open for the submission of manufacturer pricing data in the first quarter of 2019.”
NEW YORK – Earlier this year, Yeshiva University’s Katz Graduate Business School introduced a new 36-credit Master of Science in Biotechnology Management and Entrepreneurship designed to prepare future business leaders in the life sciences to successfully navigate the launching new medical drugs.
The Centers for Medicare & Medicaid Services (CMS) released an advance notice of proposed rulemaking (the ANPR) seeking comments on its proposal to dramatically change the way the agency pays for separately payable Part B drugs and biologicals.
Headlines that Matter for Companies and Executives in Regulated Industries
Headlines that Matter for Companies and Executives in Regulated Industries
On October 26, 2018, the Health Resources and Services Administration (HRSA) updated its online National Practitioner Data Bank (NPDB) Guidebook for the first time since April 2015. The Guidebook provides information to eligible entities and professionals regarding reporting to the NPDB, querying th
Byron Dorgan*, Philip S. English*, Dan H. Renberg, Jon S. Bouker, Craig Engle, Laura E. Doyle*, Daniel Sjostedt*
As the dust settles on a campaign cycle that was unprecedented in many ways, we have composed this biennial post-election analysis to assist our clients in assessing the potential impact of the elections on their organizations and their industries.
Byron Dorgan*, Philip S. English*, Dan H. Renberg, Jon S. Bouker, Craig Engle, Laura E. Doyle*, Daniel Sjostedt*
Below is a roundup of headlines that matter and key takeaways from the industries and issues we're following closely. We'll be back later today with more in-depth analysis.
WASHINGTON — Twenty-four Arent Fox LLP practices have been recognized in the 2019 “Best Law Firms” rankings that are published annually by US News & World Report and Best Lawyers.
Headlines that Matter for Companies and Executives in Regulated Industries
The Department of Health and Human Services (HHS) has issued a proposed rule (PR) which would require any television advertisement for a drug or biological covered by Medicare or Medicaid to include a disclosure of the product’s “current list price” for a “typical” thirty day supply.
President Trump signed into law a bill that expands the Open Payments reporting requirements.
President Trump is expected to sign into law a bill which will – among other things – expand the scope of the Open Payments reporting requirements mandated by Section 6002 of the Patient Protection and Affordable Care Act (often referred to as the Sunshine Act).
Headlines that Matter for Companies and Executives in Regulated Industries
On September 28, 2018, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed an amended complaint to revive its lawsuit seeking to block implementation and enforcement of California’s drug price transparency law.